Post Archive by Month

Despite limited clinical evidence, all available data suggest that intradermal administration of the Bavarian Nordic-produced Jynneos® vaccine will be as immunogenic as subcutaneous dosing for preventing monkeypox infection and illness, which leads us to favor intradermal use from both the individual and public health perspectives, wrote a group of vaccine experts.
'Vaccines work only if they are accessible, trusted, and used.'

Early in 2022, a study funded by the U.S. National Institutes of Health (NIH) found women receiving one dose of a COVID-19 vaccine during a single menstrual cycle had an increase in cycle length of nearly one day.
Recently, a large international study funded by the NIH confirmed those findings linking COVID-19 vaccination with an average increase in menstrual cycle length of less than one day.
For most study participants, the increase resolved in the cycle following vaccination.

New data announced today from four real-world studies shows the impact that cell-based and adjuvanted influenza vaccines can have in reducing the burden of seasonal influenza on hospitals and health systems.
The data from CSL Seqirus were presented at OPTIONS for the Control of Influenza (OPTIONS XI), being held in the United Kingdom.